Article
The Bcl-2 silencing with an Antisense Oligonucleotide: Increase early Apoptosis
2021-10-12
Abstract excerpt
<title>Abstract</title> <p>Background Breast cancer is a heterogenic disease and hormone dependence. Estrogen receptor is positive in more than seventy percent of breast cancer patients. Tamoxifen is an estrogen receptor (ER) antagonist and used as the first line of treatment. Drug resistance is a main reason in failure of cancer treatment and progression of the disease. Combination drug therapy is a method to t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c43a1a03-3b26-58c1-b3fd-eb974e42c3c2
- DOI
- 10.21203/rs.3.rs-936588/v1
